Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis (Q40850003)

24 September 2017

Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis (English)

1 reference

Solbritt Rantapää-Dahlqvist

24 September 2017

2

object named as

Solbritt Rantapää-Dahlqvist

0 references

Lotta Ljung

object named as

Lotta Ljung

1

0 references

Lennart T. H. Jacobsson

3

object named as

Lennart T H Jacobsson

1 reference

24 September 2017

Solbritt Rantapää-Dahlqvist

2

1 reference

PubMed ID

26984007

24 September 2017

Johan Askling

4

1 reference

PubMed ID

26984007

24 September 2017

language of work or name

English

0 references

publication date

16 March 2016

1 reference

Annals of the Rheumatic Diseases

24 September 2017

1 reference

24 September 2017

75

1 reference

24 September 2017

2087-2094

1 reference

24 September 2017

12

1 reference

Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies.

24 September 2017

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Disease activity in rheumatoid arthritis and the risk of cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Swedish registers to examine drug safety and clinical issues in RA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Smoking and risk of myocardial infarction in women and men: longitudinal population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Alcohol, smoking, coffee and risk of non-fatal acute myocardial infarction in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208995

10.1136/ANNRHEUMDIS-2015-208995

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

26984007